NCBI » Bookshelf » Cancer Medicine » Section 25: Endocrine Glands » Neoplasms of the Adrenal Cortex
 
cmed6
Cancer Medicine
6th
KufeDonald W.
MD
PollockRaphael E.
MD, PhD
WeichselbaumRalph R.
MD
BastRobert C.
Jr
MD
GanslerTed S.
MD, MBA
HollandJames F.
MD, ScD (hc)
FreiEmil
III
MD
1Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts
2Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas
3Department of Radiation and Cellular Oncology, University of Chicago Hospital, Chicago Tumor Institute, University of Chicago Chicago, Illinois
4University of Texas MD Anderson Cancer Center, Houston, Texas
5Director of Health Content, American Cancer Society, Atlanta, Georgia
6Derald H. Ruttenberg Cancer Center, Mount Sinai School of Medicine New York, New York
7Dana-Farber Cancer Institute, Harvard Medical School Boston, Massachusetts
B.C. Decker Inc.1-55009-213-82003
cancer

 Chapter 88:  Neoplasms of the Adrenal Cortex

David E. Schteingart, MD
A20554

Adrenal cortical carcinomas are rare, highly malignant tumors that account for only 0.2% of deaths due to cancer. Their incidence has been estimated at two per million people annually. About half of these tumors produce hormonal and metabolic syndromes that lead to their discovery. The other half are silent and are discovered with metastasis or when the primary tumor becomes large enough to produce abdominal symptoms.

Contents

Pathogenesis

Diagnosis

Differential Diagnosis

Imaging Characterization

Staging

Pathologic Diagnosis

Carcinoma Management

Long-term Treatment Outcome

Adrenal Function Inhibitors in Treatment

Future Prospects

References

Help ǀ Contact Bookshelf